跳至主要内容
临床试验/CTRI/2025/09/095319
CTRI/2025/09/095319尚未招募2/3 期

The Effectiveness of Agaricus Muscarius in Management of Sciatica : A Clinical Verification Study

Dr Krusha Gandhi1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2025年10月1日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
37
试验地点
1
主要终点
Sciatica Bothersomeness Index (SBI)

研究概览

简要总结

The study title The Effectiveness of Agaricus muscarius in Management of Sciatica  A Clinical Verification Study is designed to scientifically evaluate the therapeutic role of Agaricus muscarius in clinically confirmed cases of sciatica Sciatica characterized by radiating pain along the sciatic nerve due to lumbar disc herniation spinal stenosis or degenerative changes is commonly managed with conventional therapies that often provide only symptomatic relief and may have adverse effects Homeopathy with its holistic and individualized approach presents an alternative and Agaricus muscarius with its recognized action on the nervous system is frequently prescribed in neuralgic conditions resembling sciatica but lacks formal verification This analytical interventional uncontrolled clinical trial will be conducted over nine months at Smt. S. I. Patel (I) Homoeopathic Hospital Anand with purposive sampling of 37 patients aged 20–70 years from a study population of 77 Clinical assessment will be performed using the Sciatica Bothersomeness Index (SBI) with baseline and follow-up evaluations every 7–15 days for six months Prescription of Agaricus muscarius will be based on symptom similarity with potency selected according to susceptibility Data analysis will employ percentage change in SBI scores and statistical testing using paired t-test in Microsoft Excel Ethical clearance has been obtained The study aims to generate clinical evidence on the effectiveness of Agaricus muscarius in sciatica management thereby contributing to evidence-based homoeopathic practice

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patient of age group 20-70 years will be screened irrespective of gender.
  • Clinically confirmed cases of Sciatica where Agaricus muscarius is indicated will be included.
  • Only those participants who willingly give informed consent will be enrolled in the study.

排除标准

  • Individual with severe neurological deficits such as foot drop, or significant motor weakness will be excluded.
  • Pregnant or Breastfeeding female.

结局指标

主要结局

Sciatica Bothersomeness Index (SBI)

时间窗: Follow up at every 2 weeks and At the End of treatment as per the requirements of the case

次要结局

  • Not applicable(Not applicable)

研究者

发起方
Dr Krusha Gandhi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Sonal Panchmatiya

Dr V H Dave Homoeopathic Medical College

研究点 (1)

Loading locations...

相似试验